Intarcia Therapeutics

Discussion in 'Intarcia Therapeutics' started by anonymous, Mar 31, 2017 at 10:22 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

     

  2. anonymous

    anonymous Guest

    Self claimed disruptor got disrupted by FDA almost 2 years ago with a CRL and close to cease and desist on Medi-joke ITCA trials in Jan 2018.

    You just can't make this shit up! :rolleyes:
     
  3. anonymous

    anonymous Guest

    When is the next head chopping especially in Boston?
     
  4. anonymous

    anonymous Guest

    Ha ha ho ho 26% reduction in risk of cardiovascular death or hospitalization

    30% decrease worsening heart failure

    18% decrease in risk of CV death

    FARXIGA. Data Dominates Over Magic Pump
     
  5. anonymous

    anonymous Guest

    Pelaton in trouble over music copy rights. The lawsuits over use of music may impact Pelaton IPO.

    Everyone knows that the Executive Pelaton is Intarcia's center of disruption. Time2Peddle

    What will happen if the midget can't peddle OMG will the unicorn lose its horn ?
     
  6. anonymous

    anonymous Guest

    Hiring market access, product managers, sales leaders. Time2Launch
     
  7. anonymous

    anonymous Guest

    Oh really? That's funny cuz they are running out of cash and ought to be planning massive layoff end of the year. InFARTcia hasn't even resubmitted the likely DOA NDA as hey it's been over 2 years since CRL and almost 2 years to FDA demanding HALT to all Medici trials for failing safety (stability and sterility)!

    Say when will Novo's oral GLP from going to be launched again?

    PS - Boy did those jerks in Boston piss off lots of candidates 2.5 years ago. :D
     
  8. anonymous

    anonymous Guest

    you could not be more wrong. Marketing genius, multi billion dollar peak sales, disruptive unicorn transforming healthcare. Intarcia is more than just “a” product launch, we are an entirely new way of delivering healthcare, a transformative step in healthier lives and more productive people. Blessed with the best leadership team ever assembled. Our leader holds advance business degrees from Univ of Michigan, Harvard and Wharton. His leadership was first tested as Captain of the football team - a crushing middle linebacker, feared by Clemson, Penn State, and Oklahoma. He is likely to be appointed Surgeon General by the next President. His genius is our blessing and the core of our belief that humans can live longer, healthier, stronger lives through Intarcia.
     
  9. anonymous

    anonymous Guest

    Hey pissy boi too bad you couldnt pass the interviews
     
  10. anonymous

    anonymous Guest

    Are you describing new Intarcia CEO? ROFL
     
  11. anonymous

    anonymous Guest

    Sorry to blow your bubble pal but 1 of few to get invited to the Boston penthouse and let's say it was shocking as the people I met were bigger schmucks and assholes than ever imagined. Only unemployed and about to get fired will join Intarcia. Too bad they will be fired soon enough as ITCA will not get approved anytime soon if ever.
     
  12. anonymous

    anonymous Guest

    Given its litany of woes, time to change (disrupt kind that is) name! Suggestions?

    WeDisrupt
    WeGLP
    WeMedici
    WeITCA
    WehateFDA

    Inshitcia
    Infartcia
     
  13. anonymous

    anonymous Guest

    Novo takes the category to oral. Friday's approval of Rybelsus marks the death toll for injectable and idiotic surgical pump implants.
     
  14. anonymous

    anonymous Guest

    Karande was one of several executives and board members to cut ties with biotech unicorn Intarcia in the months following the FDA’s rejection of its injectable diabetes pump due to manufacturing concerns. FDA investigators observed lax processes for disinfecting surfaces, monitoring environmental conditions and ensuring that the drugs were not being contaminated, according to records obtained by the Business Journal.

    Intarcia has remained relatively silent over the ensuing two years, though a spokesperson told the Business Journal that it plans to reapply by the end of the third quarter.

    hmmm "end of the third quarter" would that be September 30, 2019 ? What happened to "mid year" ?

    too little.... too late.... where did all the money go ??
     
  15. anonymous

    anonymous Guest

    WeSUCK
     
  16. anonymous

    anonymous Guest

    Time2Disregard!
     
  17. anonymous

    anonymous Guest

    Time2Panic!

    Novo's oral GLP launching soon! No messy bloody surgeries to place and remove stupid implants and malpractice insurance claims jacking up the premium!
     
  18. anonymous

    anonymous Guest

    Time2Prosecute

    Pissing away $1.8 BILLION on generic drug outdated pump while building Boston’s most expensive office paying relatives to decorate interior raising money after FDA clearly communicated rejection is on the way

    Lies Lies and More Lies
     
  19. anonymous

    anonymous Guest

    is this a bigger scandal ? When will BOSTON Business Journal complete their investigation there’s an amazing amount of money that has disappeared
     
  20. anonymous

    anonymous Guest

    Aren't there journos canvassing Boston and Hayward for dirts on par with Theranos? Time to hire Lizard Holmes and her SE Asian BF and induct them into LT!